1h
Zacks.com on MSNModerna (MRNA) International Revenue Performance ExploredHave you assessed how the international operations of Moderna (MRNA) performed in the quarter ended December 2024? For this biotechnology company, possessing an expansive global footprint, parsing the ...
2h
Zacks.com on MSNVaccine Stocks Rise as Chinese Scientists Discover a New CoronavirusStocks of makers of COVID vaccines, Moderna MRNA, Pfizer PFE, Novavax NVAX and BioNTech BNTX rose on Friday on reports of a new bat coronavirus being discovered in China. What is the New Coronavirus?
Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...
With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...
Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
Objectives Tendinopathy is a frequent clinical problem and represents an extraordinary health economic and socioeconomic burden with high unmet medical needs. Recent clinical evidence suggests ...
As public skepticism toward mRNA vaccines grows, lawmakers in several states are taking decisive action to protect their constituents from what they deem potential risks associated with these ...
Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...
Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.
Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results